(4-butoxy-phenyl)-acetone | 4796-07-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (4-butoxy-phenyl)-acetone
• 英文别名: (4-Butoxy-phenyl)-aceton；1-(p-Butoxyphenyl)-2-propanon；1-p-Butoxyphenyl-propan-2-on；1-(4-Butoxyphenyl)propan-2-one
• CAS: 4796-07-0
• 化学式: C₁₃H₁₈O₂
• 分子量: 206.285
• InChiKey: ORJFXEFWTVQBBV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  15
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (4-butoxy-phenyl)-acetone 在 potassium tert-butylate 作用下， 生成 2-(p-Butoxyphenyl)-1.3-dimethylbutylamine
  参考文献：
  名称：

  影响血浆胆固醇和青霉素排泄的马来酰胺酸。

  摘要：

  DOI：

  10.1021/jm00316a043
• 作为产物：
  描述：

  4-丁氧基苯甲醛 在 盐酸 、 三氯化铁 、 铁粉 、 正丁胺 作用下， 生成 (4-butoxy-phenyl)-acetone
  参考文献：
  名称：

  影响血浆胆固醇和青霉素排泄的马来酰胺酸。

  摘要：

  DOI：

  10.1021/jm00316a043

文献信息

• [EN] SUBSTITUTED 3- AND 4- AMINOMETHYLPIPERIDINES FOR USE AS BETA-SECRETASE IN THE TREATMENT OF ALZHEIMER'S DISEASE<br/>[FR] 3- ET 4- AMINOMETHYLPIPERIDINES SUBSTITUEES UTILISEES COMME BETA-SECRETASE DANS LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2004002483A1

  公开（公告）日：2004-01-08

  The invention relates to novel compounds, which are substituted chiral or achiral derivatives of 3- or 4- aminomethylpiperidine of the general formula (I). The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more compounds of general formula (I) and especially their use as inhibitors of beta-secretases for the treatment of Alzheimer’s disease.

  本发明涉及新型化合物，其为通式（I）的3-或4-氨基甲基哌啶的取代手性或非手性衍生物。本发明还涉及包括制备这些化合物的工艺、含有一种或多种通式（I）化合物的药物组合物以及特别是它们作为β-分泌酶抑制剂用于治疗阿尔茨海默病的相关方面。
• 3-Arylcyclohex-2-en-1-ones and 3,6-Diarylcyclohex-2-en-1-ones. New Liquid Crystalline Compounds
  作者：Roger Brettle、David A. Dunmur、Louise D. Farrand、Nigel J. Hindley、Charles M. Marson

  DOI：10.1246/cl.1993.1663

  日期：1993.10

  The cyclohex-2-en-1-one unit flanked by one or more aryl rings is shown to provide a new system which can exhibit liquid crystal properties; these new mesogens contain a chiral centre which is both adjacent to a lateral dipolar carbonyl group and is also located in the central core.

  带有一个或多个芳香环的环己烯-2-酮单元被证明可以提供一种新的体系，具有液晶特性；这些新的介质分子含有一个手性中心，该中心既邻近一个侧向偶极的羰基基团，又位于中央核心中。
• Novel Phenoxyalkylamine Derivatives. VII. Synthesis and Pharmacological Activities of 2-Alkoxy-5-((phenoxyalkylamino)alkyl)benzenesulfonamide Derivatives.
  作者：Shunichiro SAKURAI、Kazuya MITANI、Shigeki HASHIMOTO、Koji MORIKAWA、Shingo YASUDA、Eiichi KOSHINAKA、Hideo KATO、Yasuo ITO

  DOI：10.1248/cpb.40.1443

  日期：——

  To find a novel α-blocker with high α-blocking selectivity against dopamine D2-receptor affinity, we performed structural modification of the alkylene chains and the substituents on two benzene rings of 2-alkoxy-5-[(phenoxyalkylamino)alkyl]benzenesulfonamide derivatives. The modification of the alkylene chain between the amino moiety in the center of the molecule and the benzene ring (ring A) was found to be the most significant. 5-[2-[[2-(5-Fluoro-2-methoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide (II-4), which possesses 1-methylethyl as the alkylene chain, exhibited high α-blocking selectivity as well as potent α-blocking activity.

  为了找到一种对多巴胺D2受体亲和力具有高选择性的新的α-拮抗剂，我们对2-烷氧基-5-[(苯氧烷基氨基)烷基]苯磺酰胺衍生物的烷基链及两个苯环上的取代基进行了结构改造。发现位于分子中心的氨基部分与苯环（环A）之间的烷基链的改造是最显著的。具备1-甲基乙基作为烷基链的5-[2-[[2-(5-氟-2-甲氧基苯氧基)乙基]氨基]丙基]-2-甲氧基苯磺酰胺（II-4）表现出高α-拮抗选择性以及强效的α-拮抗活性。
• Rational design, synthesis and structure–activity relationships of 4-alkoxy- and 4-acyloxy-phenylethylenethiosemicarbazone analogues as novel tyrosinase inhibitors
  作者：Ao You、Jie Zhou、Senchuan Song、Guoxun Zhu、Huacan Song、Wei Yi

  DOI：10.1016/j.bmc.2015.01.024

  日期：2015.3

  In continuing our program aimed to search for potent compounds as highly efficient tyrosinase inhibitors, here a series of novel 4-alkoxy- and 4-acyloxy-phenylethylenethiosemicarbazone analogues were designed, synthesized and their biological activities on mushroom tyrosinase were evaluated. Notably, most of compounds displayed remarkable tyrosinase inhibitory activities with IC50 value of lower than 1.0 mu M. Furthermore, the structure-activity relationships (SARs) were discussed and the inhibition mechanism and the inhibitory kinetics of selected compounds 7k and 8d were also investigated. Taken together, these results suggested that such compounds could serve as the promising candidates for the treatment of tyrosinase-related disorders and further development of such compounds might be of great interest. (C) 2015 Published by Elsevier Ltd.
• Quaternary ammonium salts of deltahydrocarbyoxyphenyl gamma-hydroxy amines
  申请人：MERCK &

  公开号：US02771469A1

  公开（公告）日：1956-11-20